Highland Capital Management (Texas)’s Repros Therapeutics Inc. RPRX Stock Holding History

Highland Capital Management (Texas)’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-248,318	Closed	-$1.84M	–	336
2015 Q3	$1.84M	Hold	248,318	–	–	0.05%	186
2015 Q2	$1.77M	Sell	248,318 -78,900	-24%	-$615K	0.04%	198
2015 Q1	$2.81M	Buy	327,218 +233,277	+248%	+$2.09M	0.06%	167
2014 Q4	$937K	Buy	+93,941	New	+$801K	0.03%	168
2013 Q3	–	Sell	-165,074	Closed	-$3.05M	–	223
2013 Q2	$3.05M	Buy	+165,074	New	+$2.92M	0.23%	67

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Highland Capital Management (Texas)'s RPRX Position: Q4 2015 in Review

Highland Capital Management (Texas) sold out of Repros Therapeutics Inc. (RPRX) in Q4 2015, closing a stake of 248,318 shares — an estimated $1.84M sold.

Highland Capital Management (Texas) first reported a position in RPRX in Q2 2013 and held it in 5 quarters. The position peaked at $3.05M in Q2 2013. 56 funds tracked by Wall St. Rank hold RPRX as of Q4 2015.

Highland Capital Management (Texas) reported no remaining Repros Therapeutics Inc. position as of Q4 2015 after selling out during the quarter.
Highland Capital Management (Texas) sold 248,318 Repros Therapeutics Inc. shares in Q4 2015, an estimated $1.84M.
Highland Capital Management (Texas) first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 5 quarters.
Highland Capital Management (Texas)'s Repros Therapeutics Inc. position peaked at $3.05M in Q2 2013.
56 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2015, filed 16 Feb 2016.